The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXtract Regulatory News (XTR)

Share Price Information for Xtract (XTR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.05
XTR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of share options

3 Jul 2020 16:00

RNS Number : 0338S
Xtract Resources plc
03 July 2020
 

 

For immediate release

3 July 2020

 

Xtract Resources Plc

("Xtract" or the "Company")

Award of Share Options

Director / PDMR Shareholding

 

Award of Share Options

The Board of Xtract announces that on 2 July 2020, the Company has awarded 19,250,000 new options over ordinary shares ("New Options"). 10,000,000 New Options (representing 2.19 per cent. of the current issued share capital) have been awarded to Directors (other than Peter Moir, Non-executive Director and Chairman of the Remuneration Committee who has approved the option award) and a further 9,250,000 New Options (representing 2.02 per cent. of the current issued share capital) have been awarded to employees, consultants and officers of the Company.

Half the New Options vest and are exercisable immediately on award, with an exercise price of 1.40p (the "First Tranche"). The remainder of the New Options have an exercise price of 2p and are subject to a share performance target and will vest as and when the Xtract share price is 2p (the "Second Tranche"). The New Options will lapse five years after the date of the award, being 1 July 2025.

The exercise price of the First Tranche represents a 18.64 per cent premium to the Xtract ordinary share mid-market closing price of 1.18p as at 2 July 2020, and a 6.52 per cent premium to the 30-day volume weighted average share price for the 30 trading days ended 2 July 2020.

Further details of the New Options awards are as follows:

Individual

Number of New Options

Directors:

Colin Bird

7,000,000

Joel Silberstein

 

3,000,000

Other PDMR(s):

Eduard Victor

5,000,000

Employees:

Other

4,250,000

Total

19,250,000

 

 

There have been no other awards of options in the prior 12-month period.

 

 

A copy of this announcement: www.xtractresources.com

 

Enquiries:

Xtract Resources Plc

Colin Bird,

Executive Chairman

 

+44 (0)20 3416 6471

www.xtractresources.com

Beaumont Cornish Limited

Nominated Adviser and Joint Broker

Roland Cornish

Michael Cornish

Felicity Geidt

+44 (0)207628 3369

www.beaumontcornish.co.uk

 

Novum Securities Limited

Joint Broker

 

Colin Rowbury

 

+44 (0)207 399 9427

www.novumsecurities.com  

 

 

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. Colin Bird

2. Joel Siberstein

3. Eduard Victor

2

 

Reason for the notification

a)

 

Position/status

 

 

1. Chairman

2. Finance Director

3. Chief Operating Officer (Non-Board)

 

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

 

Xtract Resources plc

b)

 

LEI

 

 

213800A71LZ79EKUNC34

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.02p each ("Ordinary Shares")

 

Identification code

ISIN: GB00BYSX2795

b)

 

Nature of the transaction

 

Issue of Options over Ordinary Shares

c)

 

Price(s) and volume(s)

 

Director

Price payable on exercise of option

Volume(s) 

Colin Bird

P

1.40

3,500,000

Colin Bird

P

2.00

3,500,000

Joel Silberstein

p

1.40

1,500,000

Joel Silberstein

p

2.00

1,500,000

Eduard Victor

p

1.40

2,500,000

Eduard Victor

P

2.00

2,500,000

 

 

 

 

 

 

 

 

d)

 

Aggregated information

- Aggregated volume

15,000,000 options over Ordinary Shares

- Price

7,500,000 exercisable at 1.4p

7,500,000 exercisable at 2p

e)

 

Date of the transaction

 

2 July 2020

f)

 

Place of the transaction

 

Outside a trading venue

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSSLFLDESSEEW
Date   Source Headline
18th Jun 20157:00 amRNSChepica update
5th Jun 20157:00 amRNSFinal Results
2nd Jun 20158:47 amRNSOre zone defined at Colin prospect in Chile
21st May 20157:00 amRNSExercise of Warrants
20th May 20157:00 amRNSO'Kiep Acquisition and YAGM update
13th May 20157:00 amRNSOre zone defined at Salvadori prospect in Chile
8th May 20152:48 pmRNSHolding(s) in Company
8th May 20157:00 amRNSCompletion of Placing to Raise £3m
6th May 20157:01 amRNSIncrease in Concentrate Gold grades at Chepica
29th Apr 20152:11 pmRNSHolding(s) in Company
28th Apr 20154:22 pmRNSHolding(s) in Company
23rd Apr 20157:00 amRNSHoA Signed to Evaluate Copper Dumps in SA
22nd Apr 201512:19 pmRNSDirector/PDMR Shareholding
22nd Apr 201512:00 pmRNSHolding(s) in Company
8th Apr 20157:00 amRNSChepica Milling Capacity Increased to 10,000 t/mth
30th Mar 20151:05 pmRNSPlacing to raise £1.75m
27th Mar 20157:00 amRNSAcquisition of Sulphide Copper Tailings Project
19th Mar 20152:16 pmRNSDirector/PDMR Shareholding
19th Mar 20152:11 pmRNSHolding(s) in Company
19th Mar 20157:00 amRNSAppointment of Joint Broker
18th Mar 201510:01 amRNSChepica Operational Update
17th Mar 201512:29 pmRNSHolding(s) in Company
24th Feb 201512:35 pmRNSUpdate and Successfully Re-negotiated Option Terms
9th Feb 201510:48 amRNSDirector/PDMR Shareholding
9th Feb 201510:47 amRNSHolding(s) in Company
5th Feb 20153:20 pmRNSDirector/PDMR Shareholding
5th Feb 20153:20 pmRNSHolding(s) in Company
3rd Feb 20157:00 amRNSUpdate re: Earn-in Option Agreement
20th Jan 20153:49 pmRNSDirector/PDMR Shareholding
20th Jan 201510:48 amRNSOperational Update
20th Jan 20159:22 amRNSHolding(s) in Company
19th Nov 20147:00 amRNSUS$1.3m Fund Raise and Operational Update
15th Oct 20148:02 amRNSHolding(s) in Company
2nd Oct 20147:00 amRNSSale Mejillones Phosphate Deposit
30th Sep 20147:00 amRNSHalf Yearly Report
24th Sep 20149:34 amRNSNotice of Results
15th Sep 20147:00 amRNSAppointment of Joint Broker
28th Aug 20144:42 pmRNSHolding(s) in Company TR-1 Correction
26th Aug 201412:55 pmRNSHolding(s) in Company
10th Jul 20147:00 amRNS£1.2m Raised from Disposal of 5m GOS Shares
26th Jun 201412:10 pmRNSResult of AGM
4th Jun 20143:50 pmRNSAnnual Financial Report + Notice of Meeting
3rd Jun 20147:00 amRNSFinal Results
11th Apr 20147:00 amRNSNamakwa Uranium Deposit Update
9th Apr 20147:00 amRNSCompany Update
12th Mar 201411:02 amRNSExclusive Option Extended on Namakwa Deposit in SA
10th Mar 20142:55 pmRNSNotification of Major Interest in Shares
25th Feb 20144:00 pmRNSAdmission of New Shares
24th Feb 20143:57 pmRNSResult of General Meeting
7th Feb 20141:00 pmRNSChepica Acquisition, Fundraising & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.